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Nodular fasciitis is the most common pseudosarcomatous lesion of soft tissue. Ki67 was considered as a useful
marker for distinguishing some benign and malignant lesions. To study the usefulness of Ki67 in diagnosis of
nodular fasciitis, the expression of Ki67 was examined by using immunostaining in 65 nodular fasciitis specimens,
15 desmoid fibromatosis specimens and 20 fibrosarcoma specimens. The results showed that there was a variable
Ki67 index in all 65 cases of nodular fasciitis, and the mean labeling index was 23.71±15.01%. In majority (70.77%) of
all cases,the index was ranged from 10% to 50%, in 6.15% (4/65) of cases the higher Ki67 index (over 50%) could be
seen. The Ki67 proliferative index was closely related to duration of lesion, but not to age distribution, lesion size,
sites of lesions and gender. Moreover, the mean proliferative index in desmoid fibromatosis and fibrosarcoma was
3.20±1.26% and 26.15±3.30% respectively. The mean Ki67 index of nodular fasciitis was not significantly lower than
fibrosarcoma, but higher than desmoid fibromatosis. The variable and high Ki67 index in nodular fasciitis may pose
a diagnostic challenge. We should not misdiagnose nodular fasciitis as a sarcoma because of its high Ki67 index.
The recurrence of nodular fasciitis is rare; and the utility of Ki67 immunostaining may be not suitable for recurrence
assessment in nodular fasciitis.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/4782335818876666
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Nodular fasciitis(NF) is the most common pseudo-
sarcomatous lesion of soft tissue. This lesion was often
misdiagnosed as a sarcoma because of its rapid growth,
rich cellularity, and mitotic activity [1,2]. Recently USP6
rearrangement and MYH9-USP6 gene fusions have been
identified in a high percentage of NF suggestive that this
is the driving translocation [3]. Histologically, NF is
mainly made up of plump myofibroblasts which resem-
ble the fibroblasts in tissue culture or granulation tissue,
and the background is variably myxoid or fibrous [4].
The correct diagnosis is usually based on the history of
rapid growth, lesion size and the histological appearance.* Correspondence: wangeh@hotmail.com
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reproduction in any medium, provided the orEven so, sometimes it is still hard to distinguish NF from
fibrosarcoma or myxoid fibrosarcoma. So, additional
diagnostic markers may be helpful to distinguish between
these lesions. Ki67 antigen is a cell cycle–associated nu-
clear antigen and is present in all stages of the cell cycle
(G1,S,G2, and M phases) in proliferating cells but is ab-
sent in G0 and early G1phases of cells re-entering the
cell cycle [5]. The monoclonal antibody of Ki67 protein,
MIB1, has been documented useful for the diagnosis
[6-10] and prognosis [11,12] of some neoplasms. So far,
in addition to Ki67 expression in 3 cases of nodular fasci-
itis described by Ooe M [13], there is no wide and deep
report about the expression of Ki67 in NF. To further
study the usefulness of Ki67 in diagnosis of NF, we se-
lected 65 cases of NF, 15 cases of desmoid fibromatosis
and 20 cases of fibrosarcoma, and examined the expres-
sion of Ki67 in them by immunohistochemical method.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Patients and specimens
We collected 65 cases of NF from the First Affiliated
Hospital of China Medical University from 1995 to 2009.
The patients with NF included 37 men and 28 women.
Ages of all patients ranged from 8 to 84 years, and the
average age was 37 years. The clinical findings were sum-
marized in Table 1. Postoperative follow up was obtained
in 45 patients and ranged from 12 to 66 months (mean
follow up, 31 months). In addition, 15 cases of desmoid
fibromatosis and 20 cases of fibrosarcoma were selected as
controls. All specimens were re-evaluated for diagnosis
following the criteria for classification of soft tissue tumor
by the World Health Organization (WHO). This study
was conducted according to the regulations of the institu-
tional review boards (China Medical University).Table 1 The sites, lesion size, duration and age
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All the resected specimens were fixed with 10% neutral-
buffered formalin and embedded in paraffin blocks. Tis-
sue blocks were cut into 4-μm slides, deparaffinized in
xylene, rehydrated with graded alcohols, and immuno-
stained with anti-Ki67(MIB-1, mouse monoclonal anti-
body, Santa, USA). In addition, S-100, CD34, Desmin,
cytokeratin (CK), Vimentin and α-SMA were also used
for making the diagnosis.
Sections were stained with a streptavidin-peroxidase sys-
tem (KIT-9720, Ultrasensitive TM S-P, MaiXin, China).
The chromogen used was diaminobenzidine tetrahy-
drochloride substrate (DAB kit, MaiXin, China), slightly
counterstained with hematoxylin, dehydrated and mounted.
For the negative controls, the primary antibody was re-
placed with PBS. The sections were observed under five
high power fields which showed the relatively higher Ki67
staining, and 500 tumor cells (exclusive of red cells and in-
flammatory cells) were counted in each field. The location
of Ki67 staining was on the nuclear.
Statistical analysis
All statistical calculations were performed by SPSS ver-
sion 18.0 for Windows software (SPSS Inc, IL, USA).
The chi-square test or the t test was used to compare
data from Ki67 staining. P values less than 0.05 were
considered statistically significant.
Results
Clinical findings and histological features
Of all 65 patients with NF, the majority of them suffered
the rapid growth mass, and 30.77% (20/65) of patients
had the tenderness or slight pain. The sites, lesion size,
duration and age distribution were listed in Table 1.
Histologically, all cases showed variably myxoid to
fibrous, which composed of plump immature-appearing
myofibroblasts. The cells had oval, pale-staining nuclei
with prominent nucleoli. In some cases, highly cellular
areas could be seen, and the myofibroblasts showed
plentiful mitotic figures (Figure 1).
Imunohistochemical staining
By imunohistochemical staining, all cases of NF were posi-
tive for Vimentin and SMA, negative for S-100, CD34,
Desmin and CK, and Ki67 was expressed in all 65 NF
specimens. In 23.08% (15/65) of all cases, the Ki67 labeling
index was less than 10%, while in 6.15% (4/65) Ki67 index
was over 50% (Figure 2). The majority (70.77%) of them
were ranged from 10–50% (Table 1). The mean index was
23.71±15.01%.
The mean Ki67 index in 15 cases of desmoid
fibromatosis was 3.20±1.26%, significantly lower than
that in NF (P<0.0005). The mean Ki67 index in 20 cases
Figure 1 Morphological changes of nodular fasciitis. (A) Spindle cells were diffused in extensive myxoid stroma. At the margin of the tumor, the
cells infiltrated the normal skeletal muscle tissue. (B) Focally, keloid like collagen bundles present in the peripheral area. (C) Extravasated erythrocytes,
scattered osteoclast-like giant cells were sprinkled between the plump myofibroblasts (D) Numerous mitoses (black arrow) were present.
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than that in NF (P =0.472) (Table 2).
There was no significant difference in different age
distribution, lesion size, sites of lesions and gender, while
the significant difference was found in different duration
of lesion (P =0.022). That is, the Ki67 index in cases of
NF with the duration no more than 2 months was sig-
nificantly higher than these with the duration more than
2 months (Table 3). In contrast, the Ki67 index inFigure 2 Immunohistochemical staining of α-SMA, Ki67 in nodular fas
(B) The Ki67 index was approximately 5%; (C) The Ki67 index was approximfibrosarcoma and fibromatosis was not associated with
the duration (Table 4).
Follow up
Before the end of follow up, two patients (2/45, 4.44%)
found a recurrence 18 and 26 months after the resection
respectively. One of the recurred cases was from head
and neck, another was from lower extremity. The dur-
ation was 5 months and 6 months respectively. And theciitis. (A) Nodular fasciitis showed a diffuse expression forα-SMA;
ately 20%; (D) The Ki67 index was approximately 50%.
Table 4 The relationship between Ki67 index and
duration in nodular fasciitis, fibrosarcoma and
fibromatosis
Lesion Duration (months) N Rate Mean±SD P
Nodular fasciitis ≤2 26 40.00 28.23±15.88 0.022
>2 39 60.00 19.80±13.11
Fibrosarcoma ≤2 7 35.00 26.57±3.78 0.474
>2 13 65.00 25.92±3.15
Fibromatosis ≤2 4 26.67 3.50±1.29 0.953
>2 11 73.33 3.09±1.30
Table 2 The Ki67 index in nodular fasciitis, desmoid
fibrosatois and fibrosarcoma
Lesions N Mean±SD P
Nodular fasiitis 65 23.71±14.05
Fibromatosis 15 3.20±1.26% 0.000
Fibrosarcoma 20 26.15±3.30% 0.472
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9% and 15% respectively.
Discussion
NF is a pseudosarcomatous, self-limiting reactive process
which was first described by Kornwaler et al. in 1955
as “subcutaneous pseudosarcomatous fibromatosis” [14].
Histologically, NF consists mainly of plump immature
fibroblasts that are arranged in short irregular bundles and
fascicles, accompanied by a dense reticulin meshwork with
small amounts of mature collagen. Extravasated erythro-
cytes, scattered lymphocytes and osteoclast-like giant cells
are often sprinkled between the myofibroblasts. Although
mitotic figures are fairly common, atypical mitosis is virtu-
ally never seen [2,15]. Thus, the correct diagnosis of NF
mainly depends on tumor size, short duration, red blood
cell extravasation, keloid-type collagen, and lack of mark-
edly cellular atypia. In contrast, fibrosarcoma typically
occurs in patients older than 50 years and measures moreTable 3 The expression of Ki67 in 65 cases of nodular
fasciitis with different age distribution, lesion size, sites
of lesions and gender
Characteristic N Rate Mean±SD P
Age (years)
<20 10 15.38 25.30±15.97 0.932
20-39 34 52.31 23.24±15.71
>40 21 32.31 23.71±14.05
Size (cm)
≤2 30 46.15 27.03±14.75 0.097
>2 35 53.85 20.86±14.70
Duration (months)
≤2 26 40.00 28.23±15.88 0.022
>2 39 60.00 19.80±13.11
Sites
Upper extremity 25 38.46 23.28±15.51 0.964
Trunk 18 27.69 24.06±13.82
Head and neck 10 15.38 23.00±16.49
Lower extremity 9 13.85 22.78±14.37
Others 3 4.62 30.00±20.91
Gender
Male 37 56.92 22.50±16.07 0.102
Female 28 43.08 16.67±12.28than 3 cm. The cells show more nuclear pleomorphism,
atypical mitotic figures. Fibromatosis consists of bland
cells arranged in sweeping bundles with dense collagenous
stroma and usually lacking inflammatory component,
thin-walled vessels and extravasated red blood cells.
Despite this entity has been well described, NF is still
often misdiagnosed as a sarcoma or other malignancies
because of its rapid growth, rich cellularity, and mitotic
activity. So, in addition to histological appearances, some
diagnostic markers including proliferative markers
should be used for differential diagnosis. Ki67 antigen is
a marker of proliferating cells, and is rapidly degraded
after mitosis. For the short half-time, it has been sug-
gested that Ki67 staining is more accurate and specific
than the counting of mitoses or PCNA staining [16].
Oshiro Y et al. ever reported that NF has higher expres-
sion of proliferating cell nuclear antigen than other be-
nign and malignant fibroblastic lesions [17]. However,
the utility of the proliferative markers has not been
established for distinguishing between these lesions for
diagnostic purpose [18]. So far, in addition to Ki67 ex-
pression in 3 cases of NF described by Ooe M [13], there
is no deep study on the expression of Ki67 in NF. So, to
further detect the diagnostic usefulness of Ki67, we
examined the expression of Ki67 in 65 cases of NF, 15
cases of desmoid fibromatosis and 20 cases of fibrosar-
coma. The imunohistochemical staining results showed
although Ki67 labeling index was variable in NF, there
was generally a higher expression level (mean index
23.71±15.01%). Ki67 has been proved to be a useful
marker for distinguishing many benign and malignant
lesions [6,7]. Gong et al. [19] found a significantly higher
expression of Ki67 in ghost cell odontogenic carcinoma
than in calcifying cystic odontogenic tumor. But, our re-
sults revealed that NF could show the higher expression
of Ki67. The mean Ki67 index in 15 cases of desmoid
fibrosatois is significantly lower than that in nodular
fasiitis, however, the mean Ki67 index in 20 cases of
fibrosarcoma is not significantly higher than that in NF.
This result indicates that usefulness of Ki67 staining in
differential diagnosis of NF is limited, and may represent
a diagnostic pitfall. And we should not misdiagnose the
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index. The higher proliferative index may further indicate
it is a lesion which closely mimics a sarcoma. However, in
contrast to the average index 5.6 reported by Ooe M et al.
[13], our Ki67 index is much higher. It may be because
that the numbers of specimens selected by Ooe M et al. is
too small, or the counting method is different.
In addition, we found that the Ki67 labeling index was
closely related to duration of lesion, but not to age distri-
bution, lesion size, sites of lesions and gender. This sug-
gests that if the duration was shorter, the myofibroblasts
might have the higher proliferative activities, so the cells
showed the higher expression of Ki67. That is, in the
earlier stage of the lesion, the majority of myofibroblasts
might be in immature status, conversely, if the lesion had
a long history, only few of the proliferative cells might
have high proliferative activities. In contrast, the Ki67
index in fibrosarcoma and fibromatosis was not associated
with the duration. This phenomenon may represent self-
limiting reactive process of NF. Acording to Allen, nearly
all nodules have been effectively treated by local excision,
in the series of 895 cases only 9 (1%) reappeared after
attempted complete surgical excision [20]. Thompson and
colleagues found a local recurrence rate of 9.3% in cases of
NF of the external ear, a much higher rate of local recur-
rence when compared to NF at other sites [21]. Our follow
up results reveal a 4.44% recurrence rate, generally similar
to the reported previously, indicating the recurrence of NF
is rare. Surprisingly, the Ki67 index in two recurred cases
was approximately 9% and 15% respectively, relatively not
so high. In contrast, Hoos et al. [22] and Hase-gawa et al.
[23] have reported that analysis of Ki67 can identify tumors
with aggressive behavior also among tumors with other
high-risk characteristics. That is, the higher Ki-67 index
usually means the poorer prognosis and the higher recur-
rence rate. But our finding indicated that the Ki67 staining
may be not suitable for recurrence assessment in NF.Conclusion
Our results indicate there is a variable expression in all
65 cases of NF. The variable expression of Ki67 in NF
may cause a diagnostic confusion. We should not mis-
diagnose NF as a sarcoma because of its high Ki67 ex-
pression. The Ki67 proliferative index may be related to
the duration of the leison. The Ki67 staining may be not
suitable for prognosis assessment in NF.Consent
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